| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 599,800 | 613,100 | 919,100 | 878,800 | | Cost of Revenue | 277,300 | 21,600 | 447,700 | 661,600 | | | Gross Profit | 322,500 | 591,500 | 471,400 | 217,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (61,400) | 231,900 | 41,200 | (233,300) | | Non Recurring | 25,100 | 4,000 | 1,800 | 36,200 | | Others | 168,600 | 180,100 | 161,300 | 142,500 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 191,600 | 175,500 | 267,100 | 271,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,700) | (20,500) | (130,500) | (77,000) | | Earnings Before Interest And Taxes | 186,300 | 153,400 | 138,200 | 193,700 | | Interest Expense | 31,400 | 30,400 | 31,800 | 28,600 | | Income Before Tax | 154,900 | 123,000 | 106,400 | 165,100 | | Income Tax Expense | 56,100 | 44,500 | 38,700 | 43,900 | | Minority Interest | (1,700) |
-
|
-
| (2,100) | | | | Net Income From Continuing Ops | 101,900 | 78,500 | 67,700 | 121,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 97,100 | 78,500 | 67,700 | 121,200 | | Preferred Stock And Other Adjustments | 1,100 | (600) | (500) |
-
| | | Net Income Applicable To Common Shares | $98,200 | $77,900 | $67,200 | $121,200 |
|
0.25% Nasdaq 
Income Statement
